Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 1
1983 3
1984 1
1985 3
1986 1
1989 3
1991 2
1992 2
1993 2
1994 3
1995 1
1996 2
1997 2
1998 1
1999 3
2000 1
2001 3
2002 5
2003 1
2004 3
2005 4
2006 3
2007 7
2008 6
2009 7
2010 4
2011 3
2012 4
2013 6
2014 4
2015 4
2016 5
2017 5
2018 6
2019 6
2020 4
2021 10
2022 8
2023 12
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

140 results

Results by year

Filters applied: . Clear all
Page 1
Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal.
Valent P, Akin C, Hartmann K, Alvarez-Twose I, Brockow K, Hermine O, Niedoszytko M, Schwaab J, Lyons JJ, Carter MC, Elberink HO, Butterfield JH, George TI, Greiner G, Ustun C, Bonadonna P, Sotlar K, Nilsson G, Jawhar M, Siebenhaar F, Broesby-Olsen S, Yavuz S, Zanotti R, Lange M, Nedoszytko B, Hoermann G, Castells M, Radia DH, Muñoz-Gonzalez JI, Sperr WR, Triggiani M, Kluin-Nelemans HC, Galli SJ, Schwartz LB, Reiter A, Orfao A, Gotlib J, Arock M, Horny HP, Metcalfe DD. Valent P, et al. Hemasphere. 2021 Oct 13;5(11):e646. doi: 10.1097/HS9.0000000000000646. eCollection 2021 Nov. Hemasphere. 2021. PMID: 34901755 Free PMC article. Review.
CD30 expression in MC now qualifies as a minor SM criterion, and BMM is now defined by SM criteria, absence of skin lesions and absence of B- and C-findings. A basal serum tryptase level exceeding 20 ng/mL remains a minor SM criterion, with recognition that hereditary alph …
CD30 expression in MC now qualifies as a minor SM criterion, and BMM is now defined by SM criteria, absence of skin lesions and absence of B …
The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HalphaT.
Valent P, Hoermann G, Bonadonna P, Hartmann K, Sperr WR, Broesby-Olsen S, Brockow K, Niedoszytko M, Hermine O, Chantran Y, Butterfield JH, Greiner G, Carter MC, Sabato V, Radia DH, Siebenhaar F, Triggiani M, Gülen T, Alvarez-Twose I, Staudinger T, Traby L, Sotlar K, Reiter A, Horny HP, Orfao A, Galli SJ, Schwartz LB, Lyons JJ, Gotlib J, Metcalfe DD, Arock M, Akin C. Valent P, et al. J Allergy Clin Immunol Pract. 2023 Oct;11(10):3010-3020. doi: 10.1016/j.jaip.2023.08.008. Epub 2023 Aug 10. J Allergy Clin Immunol Pract. 2023. PMID: 37572755 Free article. Review.
By applying this definition in a literature screen, the normal basal tryptase in asymptomatic controls (HalphaT-positive persons included) ranges between 1 and 15 ng/mL. This definition should avoid overinterpretation, unnecessary referrals, and unnecessary anxiety or anti …
By applying this definition in a literature screen, the normal basal tryptase in asymptomatic controls (HalphaT-positive persons included) r …
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.
Matuozzo D, Talouarn E, Marchal A, Zhang P, Manry J, Seeleuthner Y, Zhang Y, Bolze A, Chaldebas M, Milisavljevic B, Gervais A, Bastard P, Asano T, Bizien L, Barzaghi F, Abolhassani H, Abou Tayoun A, Aiuti A, Alavi Darazam I, Allende LM, Alonso-Arias R, Arias AA, Aytekin G, Bergman P, Bondesan S, Bryceson YT, Bustos IG, Cabrera-Marante O, Carcel S, Carrera P, Casari G, Chaïbi K, Colobran R, Condino-Neto A, Covill LE, Delmonte OM, El Zein L, Flores C, Gregersen PK, Gut M, Haerynck F, Halwani R, Hancerli S, Hammarström L, Hatipoğlu N, Karbuz A, Keles S, Kyheng C, Leon-Lopez R, Franco JL, Mansouri D, Martinez-Picado J, Metin Akcan O, Migeotte I, Morange PE, Morelle G, Martin-Nalda A, Novelli G, Novelli A, Ozcelik T, Palabiyik F, Pan-Hammarström Q, de Diego RP, Planas-Serra L, Pleguezuelo DE, Prando C, Pujol A, Reyes LF, Rivière JG, Rodriguez-Gallego C, Rojas J, Rovere-Querini P, Schlüter A, Shahrooei M, Sobh A, Soler-Palacin P, Tandjaoui-Lambiotte Y, Tipu I, Tresoldi C, Troya J, van de Beek D, Zatz M, Zawadzki P, Al-Muhsen SZ, Alosaimi MF, Alsohime FM, Baris-Feldman H, Butte MJ, Constantinescu SN, Cooper MA, Dalgard CL, Fellay J, Heath JR, Lau YL, Lifton RP, Maniatis T, Mogensen TH, v… See abstract for full author list ➔ Matuozzo D, et al. Genome Med. 2023 Apr 5;15(1):22. doi: 10.1186/s13073-023-01173-8. Genome Med. 2023. PMID: 37020259 Free PMC article.
Safety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine, V116, in healthy adults: phase 1/2, randomised, double-blind, active comparator-controlled, multicentre, US-based trial.
Platt H, Omole T, Cardona J, Fraser NJ, Mularski RA, Andrews C, Daboul N, Gallagher N, Sapre A, Li J, Polis A, Fernsler D, Tamms G, Xu W, Murphy R, Skinner J, Joyce J, Musey L. Platt H, et al. Lancet Infect Dis. 2023 Feb;23(2):233-246. doi: 10.1016/S1473-3099(22)00526-6. Epub 2022 Sep 15. Lancet Infect Dis. 2023. PMID: 36116461 Clinical Trial.
BACKGROUND: A pneumococcal conjugate vaccine (PCV) specifically focused on serotypes associated with adult residual disease burden is urgently needed. We aimed to assess V116, an investigational 21-valent PCV, that contains pneumococcal polysaccharides (PnPs), which accoun …
BACKGROUND: A pneumococcal conjugate vaccine (PCV) specifically focused on serotypes associated with adult residual disease burden is urgent …
Predictors of serological non-response to the 13-valent pneumococcal conjugate vaccine followed by the 23-valent polysaccharide vaccine among adults living with HIV.
Tinggaard M, Slotved HC, Jørgensen CS, Kronborg G, Benfield T. Tinggaard M, et al. Vaccine. 2023 Jul 5;41(30):4414-4421. doi: 10.1016/j.vaccine.2023.06.021. Epub 2023 Jun 12. Vaccine. 2023. PMID: 37316406 Free article.
METHODS: PLWH on antiretroviral treatment and no prior pneumococcal vaccination received the 13-valent pneumococcal conjugate vaccine (PCV13) followed 60 days later by the 23-valent polysaccharide vaccine (PPV23). ...Serotypes 14, 18C and 19F had the highest, and se …
METHODS: PLWH on antiretroviral treatment and no prior pneumococcal vaccination received the 13-valent pneumococcal conjugate vaccine …
Mastocytosis: state of the art.
Horny HP, Sotlar K, Valent P. Horny HP, et al. Pathobiology. 2007;74(2):121-32. doi: 10.1159/000101711. Pathobiology. 2007. PMID: 17587883 Free article. Review.
SM criteria include one major criterion (multifocal compact tissue infiltration by MC) and four minor criteria: (1) prominent spindling of MC; (2) atypical immunophenotype of MC with coexpression of CD2 and/or CD25 (antigens which have not been found to be expressed on normal/rea …
SM criteria include one major criterion (multifocal compact tissue infiltration by MC) and four minor criteria: (1) prominent spindling of M …
Rapid magnetic enrichment and sensitive detection of Sudan pollutants with nanoscale zero valent iron-based nanomaterials in combination with liquid chromatography-ultraviolet detector.
Zhou Q, Zhao K, Wu Y, Li S, Guo J, Zhou B, Zhao J, Guo L, Chen C. Zhou Q, et al. Chemosphere. 2021 Oct;281:130900. doi: 10.1016/j.chemosphere.2021.130900. Epub 2021 May 21. Chemosphere. 2021. PMID: 34044305
The established method provided excellent linear ranges over 0.01-50 mug L(-1) and detection limits ranged from 2.0 to 5.1 ng L(-1) for Sudan red I-IV. The developed method was also evaluated with real water samples and the results demonstrated that it was of applicative v …
The established method provided excellent linear ranges over 0.01-50 mug L(-1) and detection limits ranged from 2.0 to 5.1 ng L(-1) f …
Tryptase a novel biochemical marker of acute myeloid leukemia.
Sperr WR, Hauswirth AW, Valent P. Sperr WR, et al. Leuk Lymphoma. 2002 Dec;43(12):2257-61. doi: 10.1080/1042819021000039965. Leuk Lymphoma. 2002. PMID: 12613510 Review.
We have recently shown that myeloblasts in a group of patients with AML (approximately 40%) produce significant amounts of tryptase(s). In these patients, serum tryptase levels are elevated (> 15 ng/ml) and reflect the total burden of leukemic cells. In most cases, myel …
We have recently shown that myeloblasts in a group of patients with AML (approximately 40%) produce significant amounts of tryptase(s). In t …
Effect and mechanism of graphene structured palladized zero-valent iron nanocomposite (nZVI-Pd/NG) for water denitration.
Huang X, Zhang F, Peng K, Liu J, Lu L, Li S. Huang X, et al. Sci Rep. 2020 Jun 18;10(1):9931. doi: 10.1038/s41598-020-66725-z. Sci Rep. 2020. PMID: 32555218 Free PMC article.
To overcome this issue, this study introduced a novel synthesized nanoscale palladized zero-valent iron graphene composite (nZVI-Pd/NG) and explored its nitrate reduction efficiency. ...The nitrogen gas selectivity was enhanced from 0.4% to 15.6% at the end point co …
To overcome this issue, this study introduced a novel synthesized nanoscale palladized zero-valent iron graphene composite (nZVI-Pd/ …
140 results